{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:57:38Z","timestamp":1780991858234,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Anhui Provincial Health Research Program","award":["AHWJ2023A20430"],"award-info":[{"award-number":["AHWJ2023A20430"]}]},{"name":"Key Research and Development Plan of Jiangsu Province","award":["BE2019666"],"award-info":[{"award-number":["BE2019666"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10072-026-09132-y","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:50:42Z","timestamp":1780023042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and evolution of dural enhancement in NMOSD: A retrospective case series"],"prefix":"10.1007","volume":"47","author":[{"given":"Tieyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2304-9993","authenticated-orcid":false,"given":"Shugang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"2","key":"9132_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"issue":"9451","key":"9132_CR2","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (British edition) 364(9451):2106\u20132112. https:\/\/doi.org\/10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet (British edition)"},{"key":"9132_CR3","doi-asserted-by":"publisher","unstructured":"Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 914. https:\/\/doi.org\/10.1186\/1742-2094-9-14","DOI":"10.1186\/1742-2094-9-14"},{"issue":"10","key":"9132_CR4","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/1352458510376640","volume":"16","author":"W Kim","year":"2010","unstructured":"Kim W, Park MS, Lee SH et al (2010) Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 16(10):1229\u20131236. https:\/\/doi.org\/10.1177\/1352458510376640","journal-title":"Mult Scler"},{"issue":"11","key":"9132_CR5","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA et al (2015) Mri characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84(11):1165\u20131173. https:\/\/doi.org\/10.1212\/WNL.0000000000001367","journal-title":"Neurology"},{"issue":"1\u20132","key":"9132_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jneuroim.2014.02.006","volume":"269","author":"Y Long","year":"2014","unstructured":"Long Y, Chen M, Zhang B et al (2014) Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. J Neuroimmunol 269(1\u20132):62\u201367. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.02.006","journal-title":"J Neuroimmunol"},{"key":"9132_CR7","doi-asserted-by":"publisher","unstructured":"Kon T, Nishijima H, Haga R et al (2015) Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: a case report. J Neuroimmunol 28727\u201328728. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.08.001","DOI":"10.1016\/j.jneuroim.2015.08.001"},{"issue":"3","key":"9132_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","volume":"32","author":"K Fujihara","year":"2019","unstructured":"Fujihara K (2019) Neuromyelitis optica spectrum disorders: still evolving and broadening. Curr Opin Neurol 32(3):385\u2013394. https:\/\/doi.org\/10.1097\/WCO.0000000000000694","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"9132_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10143-015-0646-y","volume":"38","author":"J Antony","year":"2015","unstructured":"Antony J, Hacking C, Jeffree RL (2015) Pachymeningeal enhancement\u2014a comprehensive review of literature. Neurosurg Rev 38(4):649\u2013659. https:\/\/doi.org\/10.1007\/s10143-015-0646-y","journal-title":"Neurosurg Rev"},{"issue":"1","key":"9132_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12026-016-8863-1","volume":"65","author":"A De Virgilio","year":"2017","unstructured":"De Virgilio A, de Vincentiis M, Inghilleri M et al (2017) Idiopathic hypertrophic pachymeningitis: an autoimmune igg4-related disease. Immunol Res 65(1):386\u2013394. https:\/\/doi.org\/10.1007\/s12026-016-8863-1","journal-title":"Immunol Res"},{"issue":"6","key":"9132_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.sult.2009.08.006","volume":"30","author":"N Patel","year":"2009","unstructured":"Patel N, Kirmi O (2009) Anatomy and imaging of the normal meninges. Seminars Ultrasound CT MRI 30(6):559\u2013564. https:\/\/doi.org\/10.1053\/j.sult.2009.08.006","journal-title":"Seminars Ultrasound CT MRI"},{"issue":"8","key":"9132_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/acn3.221","volume":"2","author":"N Asgari","year":"2015","unstructured":"Asgari N, Berg CT, Morch MT, Khorooshi R, Owens T (2015) Cerebrospinal fluid aquaporin-4-immunoglobulin g disrupts blood brain barrier. Ann Clin Transl Neurol 2(8):857\u2013863. https:\/\/doi.org\/10.1002\/acn3.221","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"9132_CR13","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1212\/NXI.0000000000000343","volume":"4","author":"N Asgari","year":"2017","unstructured":"Asgari N, Flanagan EP, Fujihara K et al (2017) Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 4(4):e343. https:\/\/doi.org\/10.1212\/NXI.0000000000000343","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"9132_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/01.wnl.0000341278.26993.22","volume":"72","author":"M Moravan","year":"2009","unstructured":"Moravan M, Segal BM (2009) Treatment of cns sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72(4):337\u2013340. https:\/\/doi.org\/10.1212\/01.wnl.0000341278.26993.22","journal-title":"Neurology"},{"issue":"6","key":"9132_CR15","first-page":"246","volume":"6","author":"H Kl","year":"1987","unstructured":"Kl H (1987) Heterotopic neuroglial tissue in the cerebral dura mater. Clin Neuropathol 6(6):246\u2013249","journal-title":"Clin Neuropathol"},{"issue":"6","key":"9132_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1212\/WNL.0000000000007909","volume":"93","author":"T Ueno","year":"2019","unstructured":"Ueno T, Kon T, Kaneko K, Takahashi T, Tomiyama M (2019) Contrast enhancement of hypertrophic dura mater in mog antibody-associated disease. Neurology 93(6):271\u2013272. https:\/\/doi.org\/10.1212\/WNL.0000000000007909","journal-title":"Neurology"},{"issue":"1","key":"9132_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","volume":"271","author":"T K\u00fcmpfel","year":"2024","unstructured":"K\u00fcmpfel T, Giglhuber K, Aktas O et al (2024) Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (nmosd) \u2013 revised recommendations of the neuromyelitis optica study group (nemos). Part ii: attack therapy and long-term management. J Neurol 271(1):141\u2013176. https:\/\/doi.org\/10.1007\/s00415-023-11910-z","journal-title":"J Neurol"},{"issue":"3","key":"9132_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamaneurol.2013.5699","volume":"71","author":"MA Mealy","year":"2014","unstructured":"Mealy MA, Wingerchuk DM, Palace J, Greenberg BM, Levy M (2014) Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy. JAMA Neurol 71(3):324. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5699","journal-title":"JAMA Neurol"},{"issue":"4","key":"9132_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10072-018-3637-2","volume":"40","author":"Y Heo","year":"2019","unstructured":"Heo Y, Kim T (2019) Case report: hypertrophic pachymeningitis associated with sj\u00f6gren\u2019s syndrome. Neurol Sci 40(4):879\u2013882. https:\/\/doi.org\/10.1007\/s10072-018-3637-2","journal-title":"Neurol Sci"},{"issue":"2","key":"9132_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5603\/PJNNS.a2022.0012","volume":"56","author":"C Kondo","year":"2022","unstructured":"Kondo C, Mishima T, Mera H et al (2022) Hypertrophic pachymeningitis associated with sj\u00f6gren\u2019s syndrome: case report and literature review. Neurol Neurochir Pol 56(2):195\u2013196. https:\/\/doi.org\/10.5603\/PJNNS.a2022.0012","journal-title":"Neurol Neurochir Pol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09132-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:06:07Z","timestamp":1780988767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9132"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09132-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Second Affiliated Hospital of Anhui Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient to publish this manuscript and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"534"}}